VYNE Insider Trading Activity and SEC Form 4 Filings
VYNE insider trading summary
No open-market insider purchases or sales of VYNE Therapeutics Inc. (VYNE) have been reported on SEC Form 4 in the past 12 months.
Latest VYNE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 15, 2025 | Patrick G Lepore | Insider | Buy | $44K (15,000 @ $2.92) |
| Nov 15, 2023 | Patrick G Lepore | Director | Buy | $51K (13,000 @ $3.91) |
| Mar 20, 2023 | Patrick G Lepore | Director | Buy | $50K (20,000 @ $2.48) |
| Mar 20, 2023 | Mutya Harsch | Chief Legal Officer and GC | Buy | $25K (10,000 @ $2.50) |
| Nov 30, 2021 | Patrick G Lepore | Director | Buy | $13K (12,500 @ $1.02) |
| Aug 25, 2021 | Patrick G Lepore | Director | Buy | $20K (12,500 @ $1.60) |
| Aug 16, 2021 | Perceptive Advisors LLC | 10% Owner | Sell | $435K (250,000 @ $1.74) |
| Aug 16, 2021 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell | $435K (250,000 @ $1.74) |
| Aug 16, 2021 | Joseph Edelman | 10% Owner | Sell | $435K (250,000 @ $1.74) |
| Aug 13, 2021 | Perceptive Advisors LLC | 10% Owner | Sell | $460K (250,000 @ $1.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.